drugset / Trial / NCT01220726
Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a prospective, randomized, double-blind study comparing intravesical injection of BOTOX to placebo. Study subjects will be randomized (1:1 ratio) to one of the following treatment groups:
Timeline
- Start
- 2009-06
- Primary completion
- 2011-06
- Completion
- 2012-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |